Agiliti, Inc. (NYSE:AGTI) EVP Lee M. Neumann Sells 5,000 Shares of Stock

Posted by Defense World Staff on Mar 15th, 2023

Agiliti, Inc. (NYSE:AGTI – Get Rating) EVP Lee M. Neumann sold 5,000 shares of the business’s stock in a transaction that occurred on Friday, March 10th. The stock was sold at an average price of $15.28, for a total value of $76,400.00. Following the sale, the executive vice president now directly owns 53,647 shares of the company’s stock, valued at $819,726.16. The sale was disclosed in a legal filing with the SEC, which is accessible through this link.

Agiliti Price Performance

Agiliti stock opened at $14.92 on Wednesday. Agiliti, Inc. has a 12 month low of $14.15 and a 12 month high of $23.25. The company has a current ratio of 1.60, a quick ratio of 1.25 and a debt-to-equity ratio of 1.14. The business’s 50 day simple moving average is $17.72 and its 200 day simple moving average is $16.95. The company has a market cap of $2.00 billion, a price-to-earnings ratio of 71.05, a PEG ratio of 16.39 and a beta of 1.40.

Institutional Inflows and Outflows

Several institutional investors have recently made changes to their positions in the company. Wells Fargo & Company MN increased its stake in Agiliti by 180.8% in the fourth quarter. Wells Fargo & Company MN now owns 1,536 shares of the company’s stock valued at $25,000 after acquiring an additional 989 shares during the last quarter. Macquarie Group Ltd. bought a new position in Agiliti in the second quarter valued at $28,000. Group One Trading L.P. bought a new position in shares of Agiliti during the fourth quarter valued at about $31,000. Clear Street Markets LLC bought a new position in shares of Agiliti during the fourth quarter valued at about $40,000. Finally, Dark Forest Capital Management LP bought a new position in shares of Agiliti during the second quarter valued at about $99,000.

Wall Street Analysts Forecast Growth

Several equities analysts have recently issued reports on AGTI shares. Morgan Stanley lowered Agiliti from an “overweight” rating to an “equal weight” rating and set a $18.00 target price for the company. in a report on Friday, January 6th. Bank of America lowered Agiliti from a “buy” rating to a “neutral” rating and set a $19.00 target price for the company. in a report on Friday, December 16th. UBS Group reduced their target price on Agiliti to $19.00 in a report on Wednesday, November 16th. Raymond James reduced their target price on Agiliti from $22.00 to $20.00 and set an “outperform” rating for the company in a report on Tuesday, November 15th. Finally, Citigroup reduced their target price on Agiliti from $21.00 to $20.00 and set a “buy” rating for the company in a report on Wednesday, March 8th. Two investment analysts have rated the stock with a hold rating and five have issued a buy rating to the company. Based on data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $20.88.

Agiliti Company Profile

(Get Rating)

Agiliti, Inc provides end-to-end healthcare technology management and service solutions to the United States healthcare industry. It also offers comprehensive medical equipment management and service solutions to reduce capital and operating expenses, increase medical equipment and staff productivity and support improved patient safety and outcomes.